EGFR and non-small cell lung carcinoma: Another recent study has demonstrated comparable results in the radiomics models for predicting the epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancers using general radiomics features, defined as features without significant differences between CT images with or without contrast enhancement [25].